Ethosuximide Capsules and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Ethosuximide Capsules and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ethosuximide
Brand name: Zarontin
Synonyms: Ethosuximide
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ethosuximide Capsules-Insulin degludec
- Ethosuximide Capsules-Insulin Degludec (U-100) Prefilled Pens
- Ethosuximide Capsules-Insulin Degludec (U-100) Vials
- Ethosuximide Capsules-Insulin Degludec (U-200) Prefilled Pens
- Ethosuximide Capsules-Insulin degludec and liraglutide
- Ethosuximide Capsules-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Ethosuximide Oral Solution
- Insulin aspart, recombinant Subcutaneous-Ethosuximide Solution
- Insulin aspart, recombinant Subcutaneous-Ethosuximide Syrup
- Insulin aspart, recombinant Subcutaneous-Ethotoin
- Insulin aspart, recombinant Subcutaneous-Ethynodiol diacetate and Ethinyl Estradiol
- Insulin aspart, recombinant Subcutaneous-Ethyol